Vorinostat and Palliative Radiotherapy
Phase I study. Side-effects when combined with standard palliative radiotherapy.
Pelvic Cancer|Radiotherapy
DRUG: Vorinostat
DLT, continously
Phase I study. Side-effects when combined with standard palliative radiotherapy.